showing 3 related works from this author
Trapping Amorphous Intermediates of Carbonates – A Combined Total Scattering and NMR Study
2018
Crystallization via metastable phases plays an important role in chemical manufacturing, biomineralization, and protein crystallization, but the kinetic pathways leading from metastable phases to the stable crystalline modifications are not well understood. In particular, the fast crystallization of amorphous intermediates makes a detailed characterization challenging. To circumvent this problem, we devised a system that allows trapping and stabilizing the amorphous intermediates of representative carbonates (calcium, strontium, barium, manganese, and cadmium). The long-term stabilization of these transient species enabled a detailed investigation of their composition, structure, and morpho…
Mechanochemical Access to Defect-Stabilized Amorphous Calcium Carbonate
2018
Amorphous calcium carbonate (ACC) is an important precursor in the biomineralization of crystalline CaCO3. The lifetime of transient ACC in nature is regulated by an organic matrix, to use it as an intermediate storage buffer or as a permanent structural element. The relevance of ACC in material science is related to our understanding of CaCO3 crystallization pathways. ACC can be obtained by liquid–liquid phase separation, and it is typically stabilized with the help of macromolecules. We have prepared ACC by milling calcite in a planetary ball mill. The ball-milled amorphous calcium carbonate (BM-ACC) was stabilized with small amounts of Na2CO3. The addition of foreign ions in form of Na2C…
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021
Background The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for the global surveillance of familial hypercholesterolaemia through harmonisation and pooling of multinational data. In this study, we aimed to characterise the adult population with heterozygous familial hypercholesterolaemia and described how it is detected and managed globally. Methods Using FHSC global registry data, we did a cross-sectional assessment of adults (aged 18 years or older) with a clinical or genetic diagnosis of probable or definite heterozygous familial hypercholesterolaemia at the time they were entered into the registries. Dat…